{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:44:20Z","timestamp":1787031860224,"version":"build-2736575974"},"reference-count":54,"publisher":"Ubiquity Press, Ltd.","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,2,14]]},"DOI":"10.5334\/gh.1283","type":"journal-article","created":{"date-parts":[[2024,2,14]],"date-time":"2024-02-14T05:34:05Z","timestamp":1707888845000},"source":"Crossref","is-referenced-by-count":13,"title":["Rationale for a New Low-Dose Triple Single Pill Combination for the Treatment of Hypertension"],"prefix":"10.5334","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1282-1896","authenticated-orcid":false,"given":"Anthony","family":"Rodgers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5870-7936","authenticated-orcid":false,"given":"Abdul","family":"Salam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7162-2972","authenticated-orcid":false,"given":"William","family":"Cushman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2544-6861","authenticated-orcid":false,"given":"Asita","family":"de Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5470-3567","authenticated-orcid":false,"given":"Gian Luca","family":"Di Tanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4145-6461","authenticated-orcid":false,"given":"Sonali R.","family":"Gnanenthiran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4472-4468","authenticated-orcid":false,"given":"Diederick","family":"Grobbee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5949-5018","authenticated-orcid":false,"given":"Krzysztof","family":"Narkiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2084-1988","authenticated-orcid":false,"given":"Dike","family":"Ojji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7505-2599","authenticated-orcid":false,"given":"Suzanne","family":"Oparil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6292-997X","authenticated-orcid":false,"given":"Neil","family":"Poulter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1765-0195","authenticated-orcid":false,"given":"Markus P.","family":"Schlaich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9217-4937","authenticated-orcid":false,"given":"Aletta E.","family":"Schutte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2493-6407","authenticated-orcid":false,"given":"Wilko","family":"Spiering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8094-1841","authenticated-orcid":false,"given":"Bryan","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2557-7239","authenticated-orcid":false,"suffix":"Jr","given":"Jackson T.","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2225-383X","authenticated-orcid":false,"given":"Paul","family":"Whelton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3285","reference":[{"issue":"10258","key":"key20240214062806_B1","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","article-title":"Global burden of 87 risk factors in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","year":"2020","journal-title":"The Lancet"},{"issue":"12","key":"key20240214062806_B2","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1111\/jch.13741","article-title":"S\u00e3o Paulo call to action for the prevention and control of high blood pressure: 2020","volume":"21","year":"2019","journal-title":"The Journal of Clinical Hypertension"},{"issue":"6","key":"key20240214062806_B3","first-page":"e13","article-title":"2017 ACC\/AHA\/AAPA\/ABC\/ACPM\/AGS\/APhA\/ASH\/ASPC\/NMA\/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"71","year":"2018","journal-title":"Hypertension"},{"issue":"33","key":"key20240214062806_B4","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","year":"2018","journal-title":"European Heart Journal"},{"issue":"9","key":"key20240214062806_B5","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1001\/jama.2013.184182","article-title":"Prevalence, Awareness, Treatment, and Control of Hypertension in Rural and Urban Communities in High-, Middle-, and Low-Income Countries","volume":"310","year":"2013","journal-title":"JAMA"},{"issue":"10199","key":"key20240214062806_B6","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0140-6736(19)31629-0","article-title":"Fixed-dose combination antihypertensive medications","volume":"394","year":"2019","journal-title":"The Lancet"},{"issue":"4","key":"key20240214062806_B7","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1161\/HYPERTENSIONAHA.119.14360","article-title":"Trends in Antihypertensive Medication Monotherapy and Combination Use Among US Adults, National Health and Nutrition Examination Survey 2005\u20132016","volume":"75","year":"2020","journal-title":"Hypertension"},{"issue":"6","key":"key20240214062806_B8","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1097\/HJH.0000000000002453","article-title":"2020 International Society of Hypertension global hypertension practice guidelines","volume":"38","year":"2020","journal-title":"Journal of Hypertension"},{"key":"key20240214062806_B9","unstructured":"World Health Organization. Guideline for the pharmacological treatment of hypertension in adults. https:\/\/iris.who.int\/bitstream\/handle\/10665\/344424\/9789240033986-eng.pdf?sequence=1 (accessed 31 January 2024)."},{"issue":"3","key":"key20240214062806_B10","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.amjmed.2008.09.038","article-title":"Combination Therapy Versus Monotherapy in Reducing Blood Pressure: Meta-analysis on 11,000 Participants from 42 Trials","volume":"122","year":"2009","journal-title":"The American Journal of Medicine"},{"issue":"9","key":"key20240214062806_B11","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1097\/HJH.0000000000002096","article-title":"Efficacy and safety of dual combination therapy of blood pressure-lowering drugs as initial treatment for hypertension","volume":"37","year":"2019","journal-title":"Journal of Hypertension"},{"issue":"4","key":"key20240214062806_B12","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1161\/HYPERTENSIONAHA.108.123455","article-title":"A Simplified Approach to the Treatment of Uncomplicated Hypertension","volume":"53","year":"2009","journal-title":"Hypertension"},{"issue":"12","key":"key20240214062806_B13","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1097\/00004872-200412000-00021","article-title":"Comparison of different therapeutic strategies in hypertension","volume":"22","year":"2004","journal-title":"Journal of Hypertension"},{"issue":"1","key":"key20240214062806_B14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/HYPERTENSIONAHA.117.09202","article-title":"Efficacy and Safety of Quarter-Dose Blood Pressure\u2013Lowering Agents","volume":"70","year":"2017","journal-title":"Hypertension"},{"issue":"7404","key":"key20240214062806_B15","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1136\/bmj.326.7404.1427","article-title":"Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials","volume":"326","year":"2003","journal-title":"BMJ"},{"issue":"7","key":"key20240214062806_B16","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1001\/jamacardio.2017.1421","article-title":"Systolic Blood Pressure Reduction and Risk of Cardiovascular Disease and Mortality","volume":"2","year":"2017","journal-title":"JAMA Cardiology"},{"issue":"10285","key":"key20240214062806_B17","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/S0140-6736(21)00590-0","article-title":"Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis","volume":"397","year":"2021","journal-title":"The Lancet"},{"issue":"2","key":"key20240214062806_B18","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1161\/01.HYP.0000254479.66645.a3","article-title":"Low-Dose Quadruple Antihypertensive Combination","volume":"49","year":"2007","journal-title":"Hypertension"},{"issue":"7","key":"key20240214062806_B19","article-title":"Randomized polypill crossover trial in people aged 50 and over","volume":"7","year":"2012","journal-title":"PLoS ONE"},{"issue":"6","key":"key20240214062806_B20","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1001\/jama.2018.10359","article-title":"Fixed Low-Dose Triple Combination Antihypertensive Medication vs Usual Care for Blood Pressure Control in Patients With Mild to Moderate Hypertension in Sri Lanka","volume":"320","year":"2018","journal-title":"JAMA"},{"issue":"10073","key":"key20240214062806_B21","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0140-6736(17)30260-X","article-title":"Quarter-dose quadruple combination therapy for initial treatment of hypertension: placebo-controlled, crossover, randomised trial and systematic review","volume":"389","year":"2017","journal-title":"The Lancet"},{"issue":"10305","key":"key20240214062806_B22","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/S0140-6736(21)01922-X","article-title":"Initial treatment with a single pill containing quadruple combination of quarter doses of blood pressure medicines versus standard dose monotherapy in patients with hypertension (QUARTET): a phase 3, randomised, double-blind, active-controlled trial","volume":"398","year":"2021","journal-title":"The Lancet"},{"issue":"1","key":"key20240214062806_B23","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1161\/HYPERTENSIONAHA.109.131300","article-title":"Triple Antihypertensive Therapy With Amlodipine, Valsartan, and Hydrochlorothiazide","volume":"54","year":"2009","journal-title":"Hypertension"},{"issue":"2","key":"key20240214062806_B24","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jash.2011.09.003","article-title":"Efficacy and safety of triple-combination therapy with olmesartan, amlodipine, and hydrochlorothiazide in study participants with hypertension and diabetes: a subpopulation analysis of the TRINITY study","volume":"6","year":"2012","journal-title":"Journal of the American Society of Hypertension"},{"issue":"7","key":"key20240214062806_B25","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1097\/HJH.0000000000001359","article-title":"Blood pressure-lowering efficacy and safety of perindopril\/indapamide\/amlodipine single-pill combination in patients with uncontrolled essential hypertension","volume":"35","year":"2017","journal-title":"Journal of Hypertension"},{"issue":"5","key":"key20240214062806_B26","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/1755-5922.12015","article-title":"Hypertension management: rationale for triple therapy based on mechanisms of action","volume":"31","year":"2013","journal-title":"Cardiovascular Therapeutics"},{"issue":"14","key":"key20240214062806_B27","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1001\/archinte.165.14.1637","article-title":"Incidence and Characteristics of Angioedema Associated With Enalapril","volume":"165","year":"2005","journal-title":"Archives of Internal Medicine"},{"key":"key20240214062806_B28","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ijcard.2016.04.132","article-title":"ACE-inhibitors versus angiotensin receptor blockers for prevention of events in cardiovascular patients without heart failure \u2014 A network meta-analysis","volume":"217","year":"2016","journal-title":"International Journal of Cardiology"},{"key":"key20240214062806_B29","article-title":"Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension","volume":"8","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"key20240214062806_B30","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.mayocp.2015.10.019","article-title":"Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers in Patients Without Heart Failure? Insights From 254,301 Patients From Randomized Trials","volume":"91","year":"2016","journal-title":"Mayo Clinic Proceedings"},{"issue":"S1","key":"key20240214062806_B31","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1038\/sj.jhh.1000991","article-title":"Clinical pharmacokinetics of angiotensin II (AT1) receptor blockers in hypertension","volume":"14","year":"2000","journal-title":"Journal of Human Hypertension"},{"key":"key20240214062806_B32","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1524-6175.2006.04482.x","article-title":"Calcium Channel Blocker Class Heterogeneity: Select Aspects of Pharmacokinetics and Pharmacodynamics","volume":"7","year":"2005","journal-title":"The Journal of Clinical Hypertension"},{"issue":"11","key":"key20240214062806_B33","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1111\/jcmm.13205","article-title":"Comparison of thiazide-like diuretics versus thiazide-type diuretics: a meta-analysis","volume":"21","year":"2017","journal-title":"Journal of Cellular and Molecular Medicine"},{"issue":"5","key":"key20240214062806_B34","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1161\/HYPERTENSIONAHA.114.05021","article-title":"Head-to-head comparisons of hydrochlorothiazide with indapamide and chlorthalidone: antihypertensive and metabolic effects","volume":"65","year":"2015","journal-title":"Hypertension"},{"issue":"5","key":"key20240214062806_B35","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1161\/HYPERTENSIONAHA.114.05122","article-title":"Effects of Thiazide-Type and Thiazide-Like Diuretics on Cardiovascular Events and Mortality","volume":"65","year":"2015","journal-title":"Hypertension"},{"issue":"6","key":"key20240214062806_B36","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1161\/HYPERTENSIONAHA.112.191106","article-title":"Chlorthalidone Compared With Hydrochlorothiazide in Reducing Cardiovascular Events","volume":"59","year":"2012","journal-title":"Hypertension"},{"issue":"6 pt 2","key":"key20240214062806_B37","article-title":"A review of 10 years of experience with indapamide as an antihypertensive agent","volume":"7","year":"1985","journal-title":"Journal of Hypertension"},{"key":"key20240214062806_B38","article-title":"Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies","volume":"338","year":"2009","journal-title":"BMJ"},{"key":"key20240214062806_B39","article-title":"FDA Briefing Document","year":"2014","journal-title":"Cardiovascular and Renal Drugs Advisory Committee Meeting September 10, 2014 To discuss the potential clinical utility of fixed combination prescription drugs composed of an antihypertensive drug, aspirin, and a statin administered to reduce the risk of cardiovascular death, nonfatal myocardial infarction, and nonfatal stroke in patients with a history of cardiovascular disease"},{"key":"key20240214062806_B40","unstructured":"ClinicalTrials.gov. Efficacy and Safety of GMRx2 Compared to Placebo for the Treatment of Hypertension (GMRx2_PCT). https:\/\/classic.clinicaltrials.gov\/ct2\/show\/NCT04518306?term=gmrx2&cond=gmrx2&draw=2&rank=1 (accessed 31 January 2024)."},{"key":"key20240214062806_B41","unstructured":"ClinicalTrials.gov. Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of Hypertension (GMRx2_ACT). https:\/\/clinicaltrials.gov\/study\/NCT04518293?tab=results (accessed 31 January 2024)."},{"issue":"8","key":"key20240214062806_B42","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1097\/HJH.0000000000002089","article-title":"Efficacy and safety of triple versus dual combination blood pressure-lowering drug therapy","volume":"37","year":"2019","journal-title":"Journal of Hypertension"},{"issue":"21","key":"key20240214062806_B43","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1136\/hrt.2010.221473","article-title":"How quickly should we titrate antihypertensive medication? Systematic review modelling blood pressure response from trial data","volume":"97","year":"2011","journal-title":"Heart"},{"key":"key20240214062806_B44","article-title":"Evaluation of pharmacokinetic drug interaction between telmisartan, amlodipine and indapamide when administered together as a fixed-dose combination in GMRx2"},{"key":"key20240214062806_B45","article-title":"Effect of food on pharmacokinetics of telmisartan, amlodipine, and indapamide fixed-dose combination (GMRx2)"},{"issue":"10","key":"key20240214062806_B46","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1177\/17474930211068671","article-title":"Triple Therapy Prevention of Recurrent Intracerebral Disease Events Trial: Rationale, design and progress","volume":"17","year":"2022","journal-title":"International Journal of Stroke"},{"issue":"10","key":"key20240214062806_B47","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1111\/jch.14009","article-title":"Two-drug fixed-dose combinations of blood pressure-lowering drugs as WHO essential medicines: An overview of efficacy, safety, and cost","volume":"22","year":"2020","journal-title":"The Journal of Clinical Hypertension"},{"issue":"10013","key":"key20240214062806_B48","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(15)00469-9","article-title":"Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data","volume":"387","year":"2016","journal-title":"The Lancet"},{"issue":"8","key":"key20240214062806_B49","article-title":"Estimating the Prevalence and Awareness Rates of Hypertension in Africa: A Systematic Analysis","volume":"9","year":"2014","journal-title":"PLoS ONE"},{"issue":"4","key":"key20240214062806_B50","first-page":"262","article-title":"Roadmap to achieve 25% hypertension control in Africa by 2025","volume":"28","year":"2017","journal-title":"Cardiovascular Journal of Africa"},{"key":"key20240214062806_B51","article-title":"Guideline on clinical investigation of medicinal products in the treatment of hypertension","author":"Committee for Medicinal Products for Human Use (CHMP)","year":"2016","journal-title":"EMA\/CHMP\/29947\/2013\/Rev. 4"},{"issue":"48","key":"key20240214062806_B52","doi-asserted-by":"crossref","first-page":"4980","DOI":"10.1093\/eurheartj\/ehac584","article-title":"Blood pressure lowering and prevention of dementia: an individual patient data meta-analysis","volume":"43","year":"2022","journal-title":"European Heart Journal"},{"key":"key20240214062806_B53","unstructured":"World Health Organization. Global report on hypertension: the race against a silent killer. https:\/\/www.who.int\/publications\/i\/item\/9789240081062 (accessed 31 January 2024)."},{"key":"key20240214062806_B54","doi-asserted-by":"crossref","first-page":"5735","DOI":"10.2147\/DDDT.S286586","article-title":"Low-Dose Triple Antihypertensive Combination Therapy in Patients with Hypertension: A Randomized, Double-Blind, Phase II Study","volume":"14","year":"2020","journal-title":"Drug Design, Development and Therapy"}],"container-title":["Global Heart"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/storage.googleapis.com\/jnl-up-j-gh-files\/journals\/1\/articles\/1283\/65cc968cf354e.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T08:01:58Z","timestamp":1761552118000},"score":1,"resource":{"primary":{"URL":"https:\/\/globalheartjournal.com\/articles\/10.5334\/gh.1283\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2,14]]}},"alternative-id":["10.5334\/gh.1283"],"URL":"https:\/\/doi.org\/10.5334\/gh.1283","relation":{},"ISSN":["2211-8179"],"issn-type":[{"value":"2211-8179","type":"print"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"18"}}